Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 13 | Malik AsthaChief Business Officer | Grant or award | A | — 70.7K sh | Mar 20, 2026 |
| 13 | Stenberg JonDirector, President & CEO | Option exercise | M | — 45.2K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 13 | McColgan Michael JDirector | Grant or award | A | — 100 sh | Mar 20, 2026 traded Mar 18, 2026 |
| 13 | Raman PrakashDirector | Grant or award | A | $13K 6,105 sh | Mar 20, 2026 traded Mar 20, 2026 |
| 13 | Winkles IsabelleChief Financial Officer | Grant or award | A | — 135.2K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 13 | Wu LeiDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $687K 16.8K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 13 | Perez-Tenessa AlejandroDirector | Grant or award | A | — 58 sh | Mar 20, 2026 traded Mar 18, 2026 |
| 13 | Mekhalfa SabrinaChief Accounting Officer | Option exercise | M | — 3,577 sh | Mar 20, 2026 traded Mar 18, 2026 |
| 13 | Malik AsthaChief Business Officer | Grant or award | A | — 117.5K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 13 | Leshinski ScottPresident | Grant or award | A | — 100.0K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 13 | Wu LeiDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $448K 10.8K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 13 | Carroll ChristinaDirector | Grant or award | A | — 51.8K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 13 | Schreiber Daniel A.Director, Chief Executive Officer | Grant or award | A | — 180.0K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 13 | Winkles IsabelleChief Financial Officer | Grant or award | A | — 84.5K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 13 | Shlimak AnnaSee Remarks | Option exercise | M | — 28.4K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 12 | Stenberg JonDirector, President & CEO | Tax withholding | F | $55K 11.9K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 12 | Antonello Katherine H.Director, President & CEO | Tax withholding | F | $205K 5,258 sh | Mar 20, 2026 traded Mar 18, 2026 |
| 12 | Duffy Kristine DDirector | Other acquisition or disposition | J | $7,495 236 sh | Mar 20, 2026 traded Mar 18, 2026 |
| 12 | Boone Travis JDirector, PRESIDENT & CEO | Tax withholding | F | $109K 10.5K sh | Mar 20, 2026 traded Mar 20, 2026 |
| 12 | Morris Philip CDirector | Other acquisition or disposition | J | $7,495 236 sh | Mar 20, 2026 traded Mar 18, 2026 |
| 12 | Bendza Gary MarkEVP, CFO | Tax withholding | F | $211K 49.5K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 12 | Dawsey James MDirector | Other acquisition or disposition | J | $14K 453 sh | Mar 20, 2026 traded Mar 18, 2026 |
| 12 | Robbins Edward Hutchinson Jr.EVP, General Counsel | Tax withholding | F | $216K 50.5K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 12 | Herraiz Lizette BenediGENERAL COUNSEL | Open-market sale · 10b5-1 plan | SELL | $238K 2,982 sh | Mar 20, 2026 traded Mar 18, 2026 |
| 11 | Dieter DavidEVP & General Counsel | Open-market sale · 10b5-1 plan | SELL | $488K 14.0K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 9 | Statham JamiSVP, General Counsel | Tax withholding | F | $5,406 4,395 sh | Mar 20, 2026 traded Mar 18, 2026 |
| 9 | Nixon D. GailSenior VP, Human Resources | Tax withholding | F | $1,849 1,249 sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Aranda RichardChief Medical Officer | Disposition to issuer | D | — 562.5K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Peterson CarynEVP, Regulatory Affairs | Grant or award | A | — 9,167 sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Aranda RichardChief Medical Officer | Grant or award | A | — 487.5K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Peterson CarynEVP, Regulatory Affairs | Disposition to issuer | D | — 157.5K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Smith Robert Paul JRChief Commercial Officer | Grant or award | A | — 562.5K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Aranda RichardChief Medical Officer | Grant or award | A | — 22.8K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Giraudo BryanCOO/CFO | Grant or award | A | — 181.3K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Giraudo BryanCOO/CFO | Disposition to issuer | D | — 176.7K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Peterson CarynEVP, Regulatory Affairs | Disposition to issuer | D | — 32.3K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | You Harry L.Director, 10% Owner | Grant or award | A | — 1.16M sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Giraudo BryanCOO/CFO | Disposition to issuer | D | — 181.3K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Wiseman SusanGeneral Counsel | Grant or award | A | — 34.6K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 9 | Peterson CarynEVP, Regulatory Affairs | Disposition to issuer | D | — 157.5K sh | Mar 20, 2026 traded Mar 19, 2026 |